Medmain Speaks

My name is Daiki, from recruitment and PR team at Medmain Inc. Today, we would like to spotlight two of our members Ryunosuke Iwakawa and Yuki Yoshida. They have been working for Medmain since the foundation of the company and are fully committed to driving our business forward. “How did they encounter Medmain…?” “What made them decide to fully commit to Medmain..?.” “What are the things they want to do in the future?

Our CEO Osamu Iizuka was selected for the Forbes 30 Under 30 - Asia’s Healthcare & Science category as announced by Forbes on April 2(JST) . 【About Forbes 30 Under 30 Asia】Forbes selects young entrepreneurs, leaders and changemakers who are under the age of 30 in their respective fields in 23 countries and regions across

Hello! This is Naoko from in recruitment / public relations team at Medmain. In this blog “Medmain Speaks”, you can find interviews with our members, company news and so on but we also would like to write a series of articles about pathology, as it is the most related area of our service. The terms such as “Pathology” “Pathologist” may not be well known generally. Today, I would like to introduce you some types of “pathology”.

Focus on the “Medmainer” - Today, we would like to spotlight one of our members from the engineering team. As an engineer, he has always held an eager-to-learn mentality and inquiring spirit. How did he join Medmain? Let’s see his story!

Medmain Inc. a Japanese health tech startup has launched its service “PidPort, a platform service for pathological image diagnosis, which includes Deep Learning driven pathological analysis.